CASUAL observations of post-mortem material have suggested an increased frequency of necrosis and other lesions in the pancreas and adjacent tissues in patients receiving certain adrenocortical ...

Background and Aim: We report our single-centre experience with endoscopic ultrasound guided fine needle aspiration (EUS-FNA) of solid pancreatic lesions with regard to clinical utility, diagnostic ...

A new report describes a new simple molecular test to detect chromosomal abnormalities -- biomarkers known as telomere fusions -- in pancreatic tumor specimens and pancreatic cyst fluids. This assay ...

Laparoscopic resection of the pancreatic tail (and sometimes body) is a fairly recent innovation that is generally reserved for pseudocysts and for presumed benign cystic lesions. It is a technically ...

A team of providers from Morgantown, W.Va.-based WVU Medicine became the first in the U.S. to treat a pancreatic lesion using endoscopic ultrasound-guided microwave ablation.  Led by Shailendra Singh, ...

Pancreatic ductal adenocarcinoma is projected to become the second-leading cause of cancer death in the United States by 2030 ...

Please provide your email address to receive an email when new articles are posted on . AI model demonstrated 94% accuracy in discerning cystic pancreatic focal lesions from solid lesions in ...

A team of scientists led by Johns Hopkins researchers have found that more than four in 10 people considered at high risk for hereditary pancreatic cancer have small pancreatic lesions long before ...

An endoscopic procedure can improve the outlook for patients with a fairly common type of pancreatic lesion that is challenging to manage and that, if left untreated, can progress to cancer, according ...

Precursor lesions of pancreatic cancer are very difficult to characterize with magnetic resonance imaging (MRI). But now, in a new study, researchers led by Noam Shemesh and Carlos Bilreiro – ...

Phase II trial of hepatic arterial infusion of fluorouracil and recombinant human interferon alfa-2b for liver metastases of colorectal cancer refractory to systemic fluorouracil and leucovorin. EUS ...